| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D24 TBC1D3F | 1.75e-09 | 279 | 83 | 12 | GO:0005096 |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 2.76e-07 | 4 | 83 | 3 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 2.76e-07 | 4 | 83 | 3 | GO:0050119 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D24 TBC1D3F | 1.19e-06 | 507 | 83 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D24 TBC1D3F | 1.19e-06 | 507 | 83 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D24 TBC1D3F | 1.64e-05 | 656 | 83 | 12 | GO:0008047 |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 3.04e-05 | 15 | 83 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 5.11e-05 | 3 | 83 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 6.96e-05 | 53 | 83 | 4 | GO:0008188 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 2.33e-04 | 133 | 83 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.95e-04 | 140 | 83 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | protein prenyltransferase activity | 4.70e-04 | 8 | 83 | 2 | GO:0008318 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 4.86e-04 | 37 | 83 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | molecular function activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D GPNMB TBC1D3I GDF1 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D24 TBC1D3F | 5.23e-04 | 1233 | 83 | 14 | GO:0140677 |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 6.03e-04 | 9 | 83 | 2 | GO:0017151 | |
| GeneOntologyMolecularFunction | deacetylase activity | 6.12e-04 | 40 | 83 | 3 | GO:0019213 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 1.10e-03 | 12 | 83 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 1.55e-03 | 55 | 83 | 3 | GO:0008146 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 1.90e-03 | 59 | 83 | 3 | GO:0008374 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 2.23e-03 | 17 | 83 | 2 | GO:0070411 | |
| GeneOntologyMolecularFunction | prenyltransferase activity | 2.50e-03 | 18 | 83 | 2 | GO:0004659 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 3.63e-03 | 74 | 83 | 3 | GO:0016782 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 4.18e-03 | 157 | 83 | 4 | GO:0052689 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 4.68e-03 | 81 | 83 | 3 | GO:0016811 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.49e-13 | 109 | 82 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.39e-09 | 244 | 82 | 11 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.83e-08 | 335 | 82 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | response to chloroquine | 6.02e-07 | 5 | 82 | 3 | GO:1902349 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B SMAD3 TBC1D3K TBC1D3F | 6.28e-07 | 499 | 82 | 12 | GO:0051345 |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 3.34e-06 | 8 | 82 | 3 | GO:0015014 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D WFIKKN1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B SMAD3 TBC1D3K TBC1D3F SP7 | 8.58e-06 | 878 | 82 | 14 | GO:0051336 |
| GeneOntologyBiologicalProcess | heparin biosynthetic process | 9.77e-06 | 11 | 82 | 3 | GO:0030210 | |
| GeneOntologyBiologicalProcess | heparin metabolic process | 3.96e-05 | 17 | 82 | 3 | GO:0030202 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system process | 1.15e-04 | 24 | 82 | 3 | GO:0031645 | |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 1.31e-04 | 25 | 82 | 3 | GO:0051481 | |
| GeneOntologyBiologicalProcess | behavior | MAP1A GALR3 AVPR1A MRGPRX1 MTNR1B MRGPRX3 MRGPRX4 SPG11 MFSD8 ACSS2 EN1 CRBN | 2.00e-04 | 891 | 82 | 12 | GO:0007610 |
| GeneOntologyBiologicalProcess | polysaccharide biosynthetic process | 2.39e-04 | 76 | 82 | 4 | GO:0000271 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan biosynthetic process | 2.39e-04 | 76 | 82 | 4 | GO:0006024 | |
| GeneOntologyBiologicalProcess | chemosensory behavior | 2.51e-04 | 31 | 82 | 3 | GO:0007635 | |
| GeneOntologyBiologicalProcess | aminoglycan biosynthetic process | 2.92e-04 | 80 | 82 | 4 | GO:0006023 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process | 3.62e-04 | 35 | 82 | 3 | GO:0015012 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 2.42e-05 | 43 | 82 | 4 | GO:0032809 | |
| GeneOntologyCellularComponent | cell body membrane | 3.45e-05 | 47 | 82 | 4 | GO:0044298 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 4.19e-04 | 8 | 82 | 2 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 6.70e-04 | 10 | 82 | 2 | GO:0071141 | |
| GeneOntologyCellularComponent | polyprenyl diphosphate synthase complex | 9.78e-04 | 12 | 82 | 2 | GO:0032476 | |
| MousePheno | decreased pruritus | 2.47e-06 | 7 | 59 | 3 | MP:0010073 | |
| MousePheno | abnormal pruritus | 1.53e-05 | 12 | 59 | 3 | MP:0010071 | |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D24 TBC1D3F | 1.29e-16 | 49 | 81 | 11 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D24 TBC1D3F | 3.32e-16 | 53 | 81 | 11 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D24 TBC1D3F | 5.17e-16 | 55 | 81 | 11 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D24 TBC1D3F | 5.17e-16 | 55 | 81 | 11 | IPR000195 |
| Domain | HSNSD | 3.13e-07 | 4 | 81 | 3 | PF12062 | |
| Domain | Heparan_SO4_deacetylase | 3.13e-07 | 4 | 81 | 3 | IPR021930 | |
| Domain | MRGPCRFAMILY | 1.26e-05 | 11 | 81 | 3 | IPR026234 | |
| Domain | TMEM183 | 1.86e-05 | 2 | 81 | 2 | IPR026509 | |
| Domain | Sulfotransferase_dom | 5.06e-04 | 36 | 81 | 3 | IPR000863 | |
| Domain | Sulfotransfer_1 | 5.06e-04 | 36 | 81 | 3 | PF00685 | |
| Domain | Dwarfin | 5.11e-04 | 8 | 81 | 2 | IPR013790 | |
| Domain | DWB | 5.11e-04 | 8 | 81 | 2 | SM00524 | |
| Domain | MH2 | 5.11e-04 | 8 | 81 | 2 | PS51076 | |
| Domain | MH1 | 5.11e-04 | 8 | 81 | 2 | PS51075 | |
| Domain | - | 5.11e-04 | 8 | 81 | 2 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 5.11e-04 | 8 | 81 | 2 | IPR013019 | |
| Domain | MH2 | 5.11e-04 | 8 | 81 | 2 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 5.11e-04 | 8 | 81 | 2 | IPR001132 | |
| Domain | Sp1_fam | 8.17e-04 | 10 | 81 | 2 | IPR030450 | |
| Domain | MBOAT_fam | 9.96e-04 | 11 | 81 | 2 | IPR004299 | |
| Domain | MBOAT | 9.96e-04 | 11 | 81 | 2 | PF03062 | |
| Domain | MAD_homology1_Dwarfin-type | 1.19e-03 | 12 | 81 | 2 | IPR003619 | |
| Domain | DWA | 1.19e-03 | 12 | 81 | 2 | SM00523 | |
| Domain | MH1 | 1.19e-03 | 12 | 81 | 2 | PF03165 | |
| Domain | SMAD_dom-like | 2.14e-03 | 16 | 81 | 2 | IPR017855 | |
| Domain | - | 2.14e-03 | 16 | 81 | 2 | 2.60.200.10 | |
| Domain | FA58C | 3.70e-03 | 21 | 81 | 2 | SM00231 | |
| Domain | FA58C_3 | 3.70e-03 | 21 | 81 | 2 | PS50022 | |
| Domain | FA58C_1 | 3.70e-03 | 21 | 81 | 2 | PS01285 | |
| Domain | FA58C_2 | 3.70e-03 | 21 | 81 | 2 | PS01286 | |
| Domain | F-box_dom | 4.24e-03 | 75 | 81 | 3 | IPR001810 | |
| Domain | F5_F8_type_C | 4.82e-03 | 24 | 81 | 2 | PF00754 | |
| Domain | FA58C | 4.82e-03 | 24 | 81 | 2 | IPR000421 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L LYZL6 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K | 8.67e-12 | 99 | 59 | 10 | M46448 |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS | 1.12e-05 | 11 | 59 | 3 | M47921 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 1.16e-04 | 23 | 59 | 3 | M511 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE | 1.69e-04 | 26 | 59 | 3 | M7330 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 2.36e-04 | 29 | 59 | 3 | MM14802 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 2.56e-04 | 6 | 59 | 2 | MM14517 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 2.88e-04 | 31 | 59 | 3 | M685 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER | 3.57e-04 | 7 | 59 | 2 | M29623 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 3.57e-04 | 7 | 59 | 2 | MM15661 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER | 4.74e-04 | 8 | 59 | 2 | M27246 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47415 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY | 4.74e-04 | 8 | 59 | 2 | M47846 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 6.63e-04 | 41 | 59 | 3 | M48095 | |
| Pathway | WP_TGFB_SMAD_SIGNALING | 1.11e-03 | 12 | 59 | 2 | M48091 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.48e-03 | 54 | 59 | 3 | MM14633 | |
| Pathway | REACTOME_FORMATION_OF_AXIAL_MESODERM | 1.52e-03 | 14 | 59 | 2 | M46441 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.74e-03 | 57 | 59 | 3 | M692 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVIN | 1.75e-03 | 15 | 59 | 2 | MM14593 | |
| Pathway | PID_SMAD2_3PATHWAY | 1.99e-03 | 16 | 59 | 2 | M228 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 1.99e-03 | 16 | 59 | 2 | MM14873 | |
| Pathway | REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION | 2.25e-03 | 17 | 59 | 2 | M45017 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING | 2.25e-03 | 17 | 59 | 2 | M39686 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.25e-03 | 17 | 59 | 2 | MM1509 | |
| Pathway | REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM | 2.25e-03 | 17 | 59 | 2 | M48030 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVIN | 2.25e-03 | 17 | 59 | 2 | M26965 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 2.25e-03 | 17 | 59 | 2 | M27946 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.17e-30 | 11 | 83 | 11 | 16863688 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 5.39e-10 | 74 | 83 | 7 | 16625196 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 28768771 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 26022362 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 27215903 | ||
| Pubmed | Proenkephalin A gene products activate a new family of sensory neuron--specific GPCRs. | 1.31e-08 | 3 | 83 | 3 | 11850634 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 10662793 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 18250432 | ||
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 31119828 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 22049073 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 12070138 | ||
| Pubmed | MrgprA3 shows sensitization to chloroquine in an acetone-ether-water mice model. | 5.23e-08 | 4 | 83 | 3 | 29064954 | |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 5.23e-08 | 4 | 83 | 3 | 12359748 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 33727332 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 10504302 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 28545921 | ||
| Pubmed | Substance P activates Mas-related G protein-coupled receptors to induce itch. | 5.23e-08 | 4 | 83 | 3 | 28219706 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 35882236 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 32234460 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 8406013 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 11821156 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 17975009 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 23074220 | ||
| Pubmed | Characterization of new G protein-coupled adenine receptors in mouse and hamster. | 5.23e-08 | 4 | 83 | 3 | 23608776 | |
| Pubmed | The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia. | 5.23e-08 | 4 | 83 | 3 | 21775281 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 26874069 | ||
| Pubmed | Tick peptides evoke itch by activating MrgprC11/MRGPRX1 to sensitize TRPV1 in pruriceptors. | 5.23e-08 | 4 | 83 | 3 | 33358893 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 36864656 | ||
| Pubmed | Low maternal care enhances the skin barrier resistance of offspring in mice. | 5.23e-08 | 4 | 83 | 3 | 31295326 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 12604796 | ||
| Pubmed | Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. | 1.31e-07 | 5 | 83 | 3 | 20004959 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 8471161 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 17618277 | ||
| Pubmed | Hippocampal short- and long-term plasticity are not modulated by astrocyte Ca2+ signaling. | 1.31e-07 | 5 | 83 | 3 | 20203048 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 38735364 | ||
| Pubmed | MrgprB4 in trigeminal neurons expressing TRPA1 modulates unpleasant sensations. | 1.31e-07 | 5 | 83 | 3 | 34116733 | |
| Pubmed | Astrocytes modulate neural network activity by Ca²+-dependent uptake of extracellular K+. | 1.31e-07 | 5 | 83 | 3 | 22472648 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 11087757 | ||
| Pubmed | Cross-sensitization of histamine-independent itch in mouse primary sensory neurons. | 1.31e-07 | 5 | 83 | 3 | 23000623 | |
| Pubmed | Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. | 1.42e-07 | 20 | 83 | 4 | 17107998 | |
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 23263443 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 33091423 | ||
| Pubmed | Genetic identification of C fibres that detect massage-like stroking of hairy skin in vivo. | 2.61e-07 | 6 | 83 | 3 | 23364746 | |
| Pubmed | Identification of a bilirubin receptor that may mediate a component of cholestatic itch. | 2.61e-07 | 6 | 83 | 3 | 30657454 | |
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 24549959 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 26216096 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 33876765 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NDST1 TMEM129 FNTB CTC1 TMEM8B PIEZO1 GRK6 THAP8 NSD1 APEH TMEM187 ADGRA2 REPIN1 TBC1D24 | 3.38e-07 | 1105 | 83 | 14 | 35748872 |
| Pubmed | Touch neurons underlying dopaminergic pleasurable touch and sexual receptivity. | 4.56e-07 | 7 | 83 | 3 | 36693373 | |
| Pubmed | FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling. | 7.28e-07 | 8 | 83 | 3 | 24067353 | |
| Pubmed | Comparative genomic analysis of eutherian Mas-related G protein-coupled receptor genes. | 7.28e-07 | 8 | 83 | 3 | 24583173 | |
| Pubmed | Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family. | 7.28e-07 | 8 | 83 | 3 | 12909716 | |
| Pubmed | 9.03e-07 | 31 | 83 | 4 | 21300867 | ||
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 12397184 | ||
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 30886406 | ||
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 33098765 | ||
| Pubmed | A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. | 2.13e-06 | 11 | 83 | 3 | 11551509 | |
| Pubmed | Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. | 2.13e-06 | 11 | 83 | 3 | 15944372 | |
| Pubmed | 2.13e-06 | 11 | 83 | 3 | 21151121 | ||
| Pubmed | 2.13e-06 | 11 | 83 | 3 | 23742838 | ||
| Pubmed | 2.84e-06 | 12 | 83 | 3 | 12460940 | ||
| Pubmed | Parallel ascending spinal pathways for affective touch and pain. | 4.68e-06 | 14 | 83 | 3 | 33116307 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26905010 | ||
| Pubmed | Cigarette smoke exacerbates mouse allergic asthma through Smad proteins expressed in mast cells. | 5.63e-06 | 2 | 83 | 2 | 21496353 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 36050359 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11984875 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33769459 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23666711 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15665291 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27012147 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18210139 | ||
| Pubmed | Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro. | 5.63e-06 | 2 | 83 | 2 | 24925688 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15520018 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30111581 | ||
| Pubmed | Origination and evolution of a human-specific transmembrane protein gene, c1orf37-dup. | 5.63e-06 | 2 | 83 | 2 | 16644869 | |
| Pubmed | The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. | 5.63e-06 | 2 | 83 | 2 | 17074756 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20010874 | ||
| Pubmed | Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. | 5.63e-06 | 2 | 83 | 2 | 16382155 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26919280 | ||
| Pubmed | Smad2 and Smad3 expressed in skeletal muscle promote immobilization-induced bone atrophy in mice. | 5.63e-06 | 2 | 83 | 2 | 34710825 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27134141 | ||
| Pubmed | Evidence for a role of Smad3 and Smad2 in stabilization of the tumor-derived mutant Smad2.Q407R. | 5.63e-06 | 2 | 83 | 2 | 12700238 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33245228 | ||
| Pubmed | Formation of the definitive endoderm in mouse is a Smad2-dependent process. | 5.63e-06 | 2 | 83 | 2 | 10862745 | |
| Pubmed | Smad2-dependent downregulation of miR-30 is required for TGF-β-induced apoptosis in podocytes. | 5.63e-06 | 2 | 83 | 2 | 24086574 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28666967 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21229365 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22385658 | ||
| Pubmed | Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile. | 5.63e-06 | 2 | 83 | 2 | 15630024 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32705438 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28099259 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26354774 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 35780861 | ||
| Pubmed | Role of SMPD3 during Bone Fracture Healing and Regulation of Its Expression. | 5.63e-06 | 2 | 83 | 2 | 30530524 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24911914 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 29174331 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19172185 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11937490 | ||
| Pubmed | The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice. | 5.63e-06 | 2 | 83 | 2 | 15133179 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 35977516 | ||
| Interaction | NDST4 interactions | 3.20e-06 | 8 | 79 | 3 | int:NDST4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D LYZL6 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.91e-17 | 149 | 83 | 12 | chr17q12 |
| Cytoband | 17q12 | 1.07e-06 | 99 | 83 | 5 | 17q12 | |
| Cytoband | 11p15.1 | 1.81e-04 | 60 | 83 | 3 | 11p15.1 | |
| Cytoband | 5q35 | 7.97e-04 | 23 | 83 | 2 | 5q35 | |
| GeneFamily | Sulfotransferases, membrane bound | 1.06e-04 | 37 | 45 | 3 | 763 | |
| GeneFamily | SMAD family | 1.68e-04 | 8 | 45 | 2 | 750 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 2.16e-04 | 9 | 45 | 2 | 755 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 9.62e-04 | 78 | 45 | 3 | 262 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.73e-11 | 90 | 79 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D PORCN GDF1 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.32e-09 | 320 | 79 | 12 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D PORCN TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.58e-09 | 213 | 79 | 10 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D PORCN TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.58e-09 | 213 | 79 | 10 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | EPHX2 ABHD15 TBC1D3 TBC1D3H TBC1D3L TBC1D3D AVPR1A TMEM8B ACSS2 LY75 EDIL3 TBC1D3G ADGRA2 TBC1D3C TBC1D3B SOAT2 SMAD3 TBC1D3K TBC1D3F | 6.80e-09 | 1049 | 79 | 19 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.88e-07 | 242 | 79 | 9 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.00e-06 | 281 | 79 | 9 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.00e-06 | 281 | 79 | 9 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | EPHX2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TMEM8B WFIKKN1 GDF1 TBC1D3G TBC1D3C TBC1D3B SMAD3 TBC1D3K TBC1D3F | 3.81e-05 | 1075 | 79 | 14 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A2 EPHX2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TMEM8B WFIKKN1 TMEM44 GDF1 TBC1D3G TBC1D3C TBC1D3B SMAD3 TBC1D3K TBC1D3F | 8.33e-05 | 1466 | 79 | 16 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.18e-06 | 182 | 83 | 6 | 9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-pDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-06 | 182 | 83 | 6 | 02c0824373a0ecebc922d4ca848ace9d570722c4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.18e-06 | 182 | 83 | 6 | 4602a98df7045e2c70b7560abfba9b444fbd5d30 | |
| ToppCell | (02)_MMP9/10+-(1)_GFP|(02)_MMP9/10+ / shred by cell type by condition | 1.97e-06 | 199 | 83 | 6 | 448ba982be804007f991d469eca9d885b21ae499 | |
| ToppCell | LAM-Lymphoid-pDC|LAM / Condition, Lineage and Cell class | 1.28e-05 | 161 | 83 | 5 | bb5b44713e4da4406cdaa79dcf2aa9f97e3cf75a | |
| ToppCell | (3)_MNP-(3)_DC_plasmacytoid|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.57e-05 | 168 | 83 | 5 | 13c160ea1a19b47d2e7e2dae818c8dcde4e3e377 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-05 | 169 | 83 | 5 | 44d201361eb497222a4972a0e10bac1e05dcfd0a | |
| ToppCell | severe_influenza-pDC|World / disease group, cell group and cell class (v2) | 1.66e-05 | 170 | 83 | 5 | b9c08af83241666bbdbed9109cadcd088c0f647d | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 1.71e-05 | 171 | 83 | 5 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.71e-05 | 171 | 83 | 5 | 1f8e66073088fc1969782e443bf00f8c1877ea91 | |
| ToppCell | severe_influenza-pDC|severe_influenza / disease group, cell group and cell class (v2) | 1.86e-05 | 174 | 83 | 5 | d8d2ded5812ed3b3db4109585714a6513c13326a | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.91e-05 | 175 | 83 | 5 | 97fe431f224b592b3076632d101e19136c138dcc | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.91e-05 | 175 | 83 | 5 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.96e-05 | 176 | 83 | 5 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-pDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-05 | 177 | 83 | 5 | e36c2005be74ee8ff03c2052504cb496faf86009 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-05 | 179 | 83 | 5 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 2.25e-05 | 181 | 83 | 5 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 2.31e-05 | 182 | 83 | 5 | 02e04294fce12591c32d7bd0e866a000ad1f836e | |
| ToppCell | (7)_DC_plasmacytoid|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.37e-05 | 183 | 83 | 5 | 2c6475c935b5a90931be6b3c53f1f707cfcd11f4 | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|normal_Lung / Location, Cell class and cell subclass | 2.37e-05 | 183 | 83 | 5 | c930b957d16f9b0904b6c424acd914532e5cc137 | |
| ToppCell | URO-Myeloid-pDC|URO / Disease, Lineage and Cell Type | 2.43e-05 | 184 | 83 | 5 | 0edb5dd003c2bca0b9e3ec18d03610d68bd52538 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.49e-05 | 185 | 83 | 5 | cc5152d3055375172bdf84f442b233c8fbd422b3 | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 2.49e-05 | 185 | 83 | 5 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | ICU-NoSEP-Myeloid-pDC|ICU-NoSEP / Disease, Lineage and Cell Type | 2.49e-05 | 185 | 83 | 5 | 7564a47df4a4e3af30d40aa0f48bd9d9c82358ae | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-05 | 186 | 83 | 5 | b70cd94c651b56dcf2e55554533a5f1130845390 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-05 | 186 | 83 | 5 | 31df1eafa3010bc1be6fc4d4689f1393d69b6b13 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-05 | 186 | 83 | 5 | eaa431ccd4cdd36fe06a44987603ec9979025aa8 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 2.56e-05 | 186 | 83 | 5 | 3d7c1a281fb82db4471283f39937007d889a5f38 | |
| ToppCell | COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease group, lineage and cell class | 2.56e-05 | 186 | 83 | 5 | 3db5ed69d49e5d79f990aca0295ddce4c297a05c | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.56e-05 | 186 | 83 | 5 | b95be984e308d4f9061274a35995ec558d434e74 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.56e-05 | 186 | 83 | 5 | 8f7949740286f64e034d1eb533ebc2c6f71ae966 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.56e-05 | 186 | 83 | 5 | 95c7318e521fb6aa02e244b1e81e6b2a62107756 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 2.62e-05 | 187 | 83 | 5 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | LAM-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 2.62e-05 | 187 | 83 | 5 | 4d9ffd2bbdf1c9869e28991ce9331e4ccf3c0166 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.69e-05 | 188 | 83 | 5 | de6a270b6e4fe09c39a52c296632d86ada98465b | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.69e-05 | 188 | 83 | 5 | 89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.69e-05 | 188 | 83 | 5 | 879054b780378ae05be68e597c77c931bf0ade03 | |
| ToppCell | myeloid-pDC|myeloid / Lineage and Cell class | 2.69e-05 | 188 | 83 | 5 | a2dc4bbeca2bdc00c51825dd65a699c54c72f241 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.76e-05 | 189 | 83 | 5 | 209cae68d78c8f72479b169e27c3ff7e143adece | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.76e-05 | 189 | 83 | 5 | a9ad1fb12304541f909dd0eeac9b9eb28c31fd41 | |
| ToppCell | COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease group, lineage and cell class | 2.76e-05 | 189 | 83 | 5 | c6cfd6aa21c19f2c62d80218bbc924e14e82aada | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group, lineage and cell class | 2.76e-05 | 189 | 83 | 5 | 46770b99da42f11f10cfc67cea8562342d60b867 | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.76e-05 | 189 | 83 | 5 | 98ca646231fbd5f29827c2dd31ac4503026bad7d | |
| ToppCell | PBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.83e-05 | 190 | 83 | 5 | adffa93635da10251f28b2089fd96b189775c8b4 | |
| ToppCell | BLOOD--(3)_MNP-(3)_DC_(cDC+pDC)|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.83e-05 | 190 | 83 | 5 | 9b8de47f7a2e6137d934ccce32417ab15eb54f46 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.83e-05 | 190 | 83 | 5 | 9a91bf1ea105029e6412d0d9060bca325299ce26 | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 2.83e-05 | 190 | 83 | 5 | e9507bb0c8ff3d071402731a9b8cfe1bba93fab0 | |
| ToppCell | MS-pDC|MS / Condition, Cell_class and T cell subcluster | 2.83e-05 | 190 | 83 | 5 | f41d7ab7d7fbcd73fddb6c3533c6a3e642e3d07f | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.83e-05 | 190 | 83 | 5 | 39c8ddc2639bf3e986dae11fbae61a735614b604 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.83e-05 | 190 | 83 | 5 | a95aea3aa707fc4574810706341a5f32b3d00209 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.83e-05 | 190 | 83 | 5 | 18dfa84c62dcf081ce9958a71e76a394ec0968e4 | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / disease group, cell group and cell class | 2.83e-05 | 190 | 83 | 5 | c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb | |
| ToppCell | MS-pDC-|MS / Condition, Cell_class and T cell subcluster | 2.83e-05 | 190 | 83 | 5 | f56ec302d556ace4f7609017a35c311cf43aa8a5 | |
| ToppCell | PBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.83e-05 | 190 | 83 | 5 | 2c1c079fd411c03bc3f383aa927eea9446716960 | |
| ToppCell | COVID-19_Moderate-pDC|World / disease group, cell group and cell class | 2.90e-05 | 191 | 83 | 5 | 93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9 | |
| ToppCell | (011)_pDC|World / immune cells in Peripheral Blood (logTPM normalization) | 2.90e-05 | 191 | 83 | 5 | d82ac4f6d9863734e09bf3cb71c1354a49b66b4f | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-05 | 191 | 83 | 5 | 8c487704cbbb5eeff54e8c6fb6fffa1472b5351f | |
| ToppCell | Healthy-pDC|World / disease group, cell group and cell class | 2.90e-05 | 191 | 83 | 5 | 6e1d825dc33b915b95f13ccd237a552160a4be98 | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 2.90e-05 | 191 | 83 | 5 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-05 | 191 | 83 | 5 | 78d523f562d32fc408a20d99b0c61cc103241bc0 | |
| ToppCell | Healthy-pDC|Healthy / disease group, cell group and cell class | 2.98e-05 | 192 | 83 | 5 | 33d695a28d22b4af111df9591830a33bb7ef7b2d | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.13e-05 | 194 | 83 | 5 | 74545942aded51a0f4ee96054b4ce12c4d99a8a0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.13e-05 | 194 | 83 | 5 | 3f9e4a8e5699bc379e8a0d337e0daef09632e71c | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.13e-05 | 194 | 83 | 5 | c25fc353001cdf9fcd772da5a254c857e555eab8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.13e-05 | 194 | 83 | 5 | 5250736b608001fb73aa74dee8cb8465a1d2f372 | |
| ToppCell | Biopsy_Other_PF-Immune-pDCs|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.37e-05 | 197 | 83 | 5 | 598a130eb7afb1bb95da64a964218362627feb49 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease, condition lineage and cell class | 3.45e-05 | 198 | 83 | 5 | 033ed362333e1d33f2aeea8da5865d2228d154dc | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class | 3.53e-05 | 199 | 83 | 5 | 9de61e5189d907cc969ac3043d68204f70acc0bf | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_smooth_muscle-like|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.09e-04 | 132 | 83 | 4 | 9633653dba1edee47d915212fb6e68426da49de5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.17e-04 | 158 | 83 | 4 | 1635a85fc73c544028418087f36d28957dd4f458 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.17e-04 | 158 | 83 | 4 | 2af7beb48272e5368d9ba6b80f08d47ab8556c08 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.17e-04 | 158 | 83 | 4 | 80841dadfa53bcde36a3e486408a095f78e772eb | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-04 | 164 | 83 | 4 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 164 | 83 | 4 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-04 | 166 | 83 | 4 | 9e98e6070055bfc780becee52d77830e06b6d854 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-04 | 167 | 83 | 4 | 650de8cd5df070639b8aa292aacead739cfdb02c | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.74e-04 | 168 | 83 | 4 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | (3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.74e-04 | 168 | 83 | 4 | 8a913db9b2a1a4ff96fb139734a3834e6aa263f1 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 170 | 83 | 4 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 2.87e-04 | 170 | 83 | 4 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 170 | 83 | 4 | 513d9036aa41d4d902da8baa66a66206abb6f3b0 | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 3.00e-04 | 172 | 83 | 4 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-04 | 172 | 83 | 4 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 3.00e-04 | 172 | 83 | 4 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.06e-04 | 173 | 83 | 4 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 83 | 4 | e0cf99ddbe6e9eab05d7bf89e9aa124850c6a807 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.13e-04 | 174 | 83 | 4 | 009e88a6c79689a5d88b0af50aa89aa03b33f800 | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 3.20e-04 | 175 | 83 | 4 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 175 | 83 | 4 | 4be01bf30331162f1998216fb2871a4e626dc440 | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 3.20e-04 | 175 | 83 | 4 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | ILEUM-inflamed-(3)_pDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.27e-04 | 176 | 83 | 4 | b9f847dd55703e413f3cd815eef5724fffaf13b3 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease state, Lineage and Cell class | 3.34e-04 | 177 | 83 | 4 | 3940663bb5b45b2ca9f772550380a516c53e410b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-04 | 177 | 83 | 4 | 507f06d31ab773099c9431b6f433899dc97b5566 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-04 | 177 | 83 | 4 | 8887ff6341eb070bdaa890cc2cd7745f0cf1b0af | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 177 | 83 | 4 | a0ff337f11bdb11959ac71805ff94be6b4ec1083 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 3.41e-04 | 178 | 83 | 4 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 178 | 83 | 4 | 0b59e3d75b143bd7bf91a7800a49699c51e68c5a | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 3.41e-04 | 178 | 83 | 4 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | Control-Myeloid-pDC|World / Disease state, Lineage and Cell class | 3.41e-04 | 178 | 83 | 4 | 20ef63d925e67ddd5955832312ca8574a6f838a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.48e-04 | 179 | 83 | 4 | 124da6f882968dc0d05f3edd8f3b4d61617cc214 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.36e-05 | 152 | 71 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | superoxide dismutase [Mn]; mitochondrial measurement | 3.41e-05 | 4 | 71 | 2 | EFO_0021981 | |
| Disease | azoospermia (implicated_via_orthology) | 3.75e-05 | 27 | 71 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | Loeys-Dietz Syndrome | 1.19e-04 | 7 | 71 | 2 | C2697932 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.58e-04 | 8 | 71 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | repulsive guidance molecule A measurement | 2.03e-04 | 9 | 71 | 2 | EFO_0008273 | |
| Disease | transmembrane glycoprotein NMB measurement | 2.54e-04 | 10 | 71 | 2 | EFO_0008303 | |
| Disease | intellectual disability (implicated_via_orthology) | 7.96e-04 | 75 | 71 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | apolipoprotein A 1 measurement | 9.69e-04 | 848 | 71 | 8 | EFO_0004614 | |
| Disease | acetate measurement | 1.05e-03 | 20 | 71 | 2 | EFO_0010112 | |
| Disease | CCL4 measurement | 1.05e-03 | 20 | 71 | 2 | EFO_0004751 | |
| Disease | Autism Spectrum Disorders | 1.14e-03 | 85 | 71 | 3 | C1510586 | |
| Disease | Left Ventricle Remodeling | 1.16e-03 | 21 | 71 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 1.16e-03 | 21 | 71 | 2 | C0600519 | |
| Disease | left atrial function | 1.16e-03 | 21 | 71 | 2 | EFO_0004294 | |
| Disease | aspartate measurement | 1.52e-03 | 24 | 71 | 2 | EFO_0010462 | |
| Disease | Lynch syndrome (is_implicated_in) | 1.52e-03 | 24 | 71 | 2 | DOID:3883 (is_implicated_in) | |
| Disease | upper respiratory tract disorder | 2.07e-03 | 28 | 71 | 2 | MONDO_0004867 | |
| Disease | lumbar disc degeneration | 2.07e-03 | 28 | 71 | 2 | EFO_0004994 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSWLGHLFLFPRWSY | 151 | Q2NKJ3 | |
| RDHSPYCWLVWRPSL | 911 | Q96PE1 | |
| PGWRRWNFIYVFHTL | 166 | Q14956 | |
| DLPWFRTLSWYFLLC | 121 | O95674 | |
| HCPAGWRSLWIGYSF | 1611 | P08572 | |
| KFHCANLTSWPRWLY | 231 | Q96SW2 | |
| AWLWYHRVVGAQRCP | 446 | Q9NR19 | |
| LRCREWFEAGLPWPY | 266 | Q6UXT9 | |
| EVCRWSSWYNGHRPE | 1336 | Q9HC84 | |
| RCLVPGWYASHIERW | 741 | O95803 | |
| RYRWWPAEICHPRAV | 1766 | Q96L73 | |
| YAHWGPRWAFSLVCG | 476 | Q8NHS3 | |
| RYFWRRSHWNPEPEF | 311 | P09238 | |
| FTSYLHVLPLWFWCP | 136 | Q96PD6 | |
| HVLPLWFWCPVFREY | 141 | Q96PD6 | |
| MRCREWYGWHFPELG | 181 | Q9Y2X3 | |
| YWRELSCERKVWFPH | 1696 | P78559 | |
| WVEWRLHCSGRPLFY | 126 | O75951 | |
| NYVRRWDWKFGDIPC | 86 | Q8TDS4 | |
| WCVRCHEPRWSYRAG | 136 | Q8TBE3 | |
| WHRWVIAPRGFLANY | 281 | P27539 | |
| IYRRWHTPLHICLIW | 151 | P49286 | |
| SHWRECLFYPALWPQ | 96 | Q7Z6M2 | |
| IGWRCPHYLWDCFRI | 251 | A6H8Z2 | |
| CLVPGWYATHIERWL | 751 | P52848 | |
| KVFHRPWRRGWHFYD | 756 | O60449 | |
| PWRRGWHFYDDREFI | 761 | O60449 | |
| RHLELWVGYYIRWNP | 571 | Q13614 | |
| WPIWYHCRRPRYLSS | 126 | Q96LB0 | |
| CLVPGWYAVHIERWL | 741 | Q9H3R1 | |
| WALIFPCYWLVDRLA | 21 | Q9NY59 | |
| VWPAWVYCTRYSDRP | 271 | Q05925 | |
| SHWVTFGCWIFYRLI | 446 | Q9H237 | |
| GVSYWRVPHELIECW | 221 | Q6PI47 | |
| LCWGPHHALILCFWY | 246 | O60755 | |
| IYARHIRILPWSWYG | 451 | O43854 | |
| VCLCHGFPESWYSWR | 261 | P34913 | |
| LDASRPWLCYWILHS | 96 | P49356 | |
| RWLLTAAHCRKPYLW | 56 | Q9UKQ9 | |
| QFRDYCAICLRWEWP | 601 | Q5W0V3 | |
| RYTFSPDWWALGCLL | 361 | P43250 | |
| WRIGPLRCYGDRRFW | 776 | Q8WYK1 | |
| WLVEFYAPWCGHCQR | 46 | Q15084 | |
| LWQHDEPCYWRLTRV | 86 | P82930 | |
| ISRQLWWGHRIPAYF | 721 | P26640 | |
| FRPGLYWRLCWKFVS | 511 | P23975 | |
| HFTPSCFQWRWGVRY | 61 | Q8NA92 | |
| CFQWRWGVRYLRPDA | 66 | Q8NA92 | |
| PCIWWKAISYHYVRR | 161 | Q8IW70 | |
| RLFDWWHPQYPFSLR | 361 | Q1AE95 | |
| SYGTWHHRCWLLGRL | 106 | Q92696 | |
| HPAYWRFWLCVSVVY | 121 | Q9BVG9 | |
| RWHSGDRPFVCNWLF | 276 | Q3SY56 | |
| WPIWYRCHRPTHLSA | 126 | Q96LB2 | |
| GPWFRHYDFRQSCWV | 466 | B9A6J9 | |
| WPIWYRCRRPTHLSA | 126 | Q96LA9 | |
| FPGWVALWLHTRRCQ | 66 | Q9BWE0 | |
| WYARRHCPLPQATFW | 496 | O75908 | |
| VGWWHEPFRLGIRFC | 261 | P13798 | |
| WPHLYGTADRCWLHL | 486 | Q9BY15 | |
| GRCCLEGPFWHFLWE | 76 | Q96JI7 | |
| DWQRWLFGELPLCYF | 211 | Q9ULP9 | |
| GPWFRHYDFRQSCWV | 466 | A6NDS4 | |
| GPWFRHYDFRQSCWV | 466 | P0C7X1 | |
| RLFDWWHPQYPFSLR | 361 | Q8IXX5 | |
| GPWFRHYDFRQSCWV | 466 | A6NER0 | |
| RWHTGERPFVCNWLF | 316 | Q8TDD2 | |
| VIYCRLWRWPDLHSH | 126 | Q15796 | |
| VIYCRLWRWPDLHSH | 86 | P84022 | |
| YRRFPDWLDHWMLCR | 276 | Q687X5 | |
| LWDWDYLDRCFARHR | 11 | Q2T9K0 | |
| GPWFRHYDFRQSCWV | 466 | A0A087X179 | |
| WRRWLFYLCPGSLIA | 376 | A6NDV4 | |
| WDITYRFRGPDWLCR | 111 | P37288 | |
| WDPVRYDLTGWLHRA | 1091 | Q8IUG5 | |
| WEPRWAYSPLLQQCH | 371 | Q96NZ8 | |
| PIFAWPVAWCLYLDR | 121 | Q14656 | |
| GPWFRHYDFRQSCWV | 466 | A0A087WVF3 | |
| PALCIDYPWRWSRAV | 1061 | Q92508 | |
| IYYWSRDRWACHPLA | 111 | A0AVI4 | |
| CYAWLVPLALWGFLR | 171 | Q9BWQ6 | |
| GPWFRHYDFRQSCWV | 466 | Q6DHY5 | |
| GPWFRHYDFRQSCWV | 466 | Q8IZP1 | |
| GPWFRHYDFRQSCWV | 466 | A0A087X1G2 | |
| GPWFRHYDFRQSCWV | 466 | A0A087WXS9 | |
| GPWFRHYDFRQSCWV | 466 | Q6IPX1 |